A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...] …
Month: October 2023
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
If you have one or more agreements with 340B Third Party Administrator(s) (TPA) to manage your contract pharmacy arrangements, how much do you know about those contracts and associated fees? Chances are, you don’t know the answers to all the questions that follow. Be
…
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: It is critical to ensure that ONLY items your Covered Entity (CE) considers eligible are included in the data file that is
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Despite calls for reform by opponents, 340B enjoys broad bipartisan support. On the legislative front, lawmakers have introduced multiple bills in the House and Senate that, if enacted, would alter program operations. Multiple court cases regarding contract pharmacy use are working their way through the judicial
…
The deadline has passed for two health systems to respond to an influential senator’s probe into 340B revenue, and at [...] …
